Weekly News Amount
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
SiLuDiYiYao is a biomedical company engaged in the research and development and commercialization of a new generation of tumor immunotherapy drugs, which is currently in the stage of late clinical development and early commercial layout. Due to the needs of business development, the original company, Thinking Di, was split into two independent companies, Thinking Di Diagnostics and SiLuDiYiYao, which are planned to be listed at home and abroad respectively


Funding 1 Fundings
Date Amount Round Relative News
Oct 2020 969.999999 million USD Undisclosed SiLuDiYiYao completed the first round of financing after the spin-off of RMB 970 million


Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info


Intelligence 0 Research Briefs


Competitors 0 Competitors